What other treatments are available for greater trochanteric bursitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment Options for Greater Trochanteric Bursitis

For greater trochanteric bursitis, start with targeted physiotherapy combined with oral anti-inflammatories, as physiotherapy provides superior long-term outcomes with 60.5% symptom resolution at 15 months 1.

First-Line Treatment Algorithm

Initial Conservative Management (0-3 months)

Physiotherapy is your primary treatment:

  • Structured, targeted PT programs show the best long-term results compared to other modalities 1
  • 60.5% of patients achieve symptom resolution at 15 months with PT alone 1
  • Benefits may not be immediate—set patient expectations accordingly

Oral anti-inflammatories (NSAIDs):

  • Used by 57.1% of surgeons as first-line treatment 2
  • Combine with PT for optimal results

For Acute Symptom Relief

Corticosteroid injections (CSI):

  • Provide short-term pain relief but inferior long-term outcomes compared to PT 1
  • Most effective when combined with PT rather than used alone 1
  • Used by 45.2% of surgeons in practice 2
  • Symptom resolution ranges from 49-100% when used as primary treatment 3

Critical caveat: CSI alone is less effective than PT for sustained benefit—always combine them 1.

Second-Line Options for Refractory Cases

Extracorporeal Shock Wave Therapy (ESWT)

  • Demonstrates 68.3% improvement in pain scores versus controls 1
  • Two comparative studies (level II and III evidence) found low-energy shock wave therapy superior to other nonoperative modalities 3
  • Low risk of adverse effects 1
  • Consider when initial conservative measures fail

Platelet-Rich Plasma (PRP)

  • Shows promise with significant VAS score reduction and improved functional outcomes (mHHS, WOMAC scores) 4
  • Minimal, mild, and transient side effects 4
  • However, evidence remains inconclusive—ongoing research needed before routine recommendation 1
  • Not yet part of standard treatment protocols 1

Third-Line: Advanced Interventions

Peripheral Nerve Stimulation (PNS)

  • Emerging option for cases unresponsive to conservative treatments 5
  • One case report showed 90-95% pain reduction sustained at 24 months 5
  • Targets the trochanteric branch of the femoral nerve 5
  • Consider for chronic, refractory cases

Surgical Options (Last Resort)

Reserved for persistent symptoms after failed conservative and medical treatments:

Endoscopic procedures:

  • Bursectomy with iliotibial band (ITB) release 6
  • The ITB must be addressed, not just bursa removal 6

Open surgical techniques 3:

  • Longitudinal ITB release
  • Proximal or distal Z-plasty
  • Bursectomy
  • Gluteus medius tear repair (if present)

All surgical techniques show superior VAS and Harris Hip Scores compared to corticosteroid therapy and PT alone in refractory cases 3.

Diagnostic Imaging Considerations

Ultrasound is useful for:

  • Confirming trochanteric bursitis diagnosis 7
  • Guiding injections 7
  • Evaluating soft tissue structures around the hip 7

MRI (without IV contrast):

  • Best for evaluating surrounding soft tissues including trochanteric bursitis, abductor tendinosis/tears 7
  • Use when diagnosis is uncertain or to rule out other pathology 7

Common Pitfalls to Avoid

  1. Don't rely on CSI alone—always combine with structured PT for sustained benefit
  2. Don't expect immediate results from PT—counsel patients that improvements take time
  3. Don't rush to surgery—up to one-third of patients fail initial therapy, but exhaust conservative options first 2
  4. Don't use PRP as standard treatment yet—evidence is still insufficient despite promising results

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.